Allergy Therapeutics plc

AGYTF · OTC
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Assets
Cash & Equivalents$17,558$12,715$14,645$20,515
Short-Term Investments$0$0$200$0
Receivables$10,944$7,285$2,366$9,207
Inventory$13,915$12,744$11,593$11,410
Other Curr. Assets-$7,740$738$4,722$1,261
Total Curr. Assets$34,677$33,482$33,526$42,393
Property Plant & Equip (Net)$24,258$23,745$23,241$20,190
Goodwill$4,565$3,317$3,346$3,347
Intangibles$1,278$1,370$1,790$1,688
Long-Term Investments$0$0$0$0
Tax Assets$1,513$0$0$0
Other NC Assets$1,252$2,913$4,866$5,962
Total NC Assets$32,866$31,345$33,243$31,187
Other Assets$0$0$0$0
Total Assets$67,543$64,827$66,769$73,580
Liabilities
Payables$4,491$4,015$4,090$4,282
Short-Term Debt$1,880$2,116$1,803$2,268
Tax Payable$1,427$4,734$4,443$4,267
Deferred Revenue$0$0$0$0
Other Curr. Liab.$29,531$9,680$8,229$6,984
Total Curr. Liab.$37,329$20,545$18,565$17,801
LT Debt$58,209$28,872$34,186$8,261
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$68$382$454$406
Other NC Liab.$10,267$11,319$11,498$8,463
Total NC Liab.$68,544$40,573$46,138$17,130
Other Liabilities$0$0$0$0
Cap. Leases$6,644$7,888$8,902$8,080
Total Liabilities$131,426$61,118$64,703$35,183
Equity
Pref Stock$0$0$0$0
Common Stock$6,543$4,766$679$644
Retained Earnings-$267,831-$198,927-$161,870-$118,542
AOCI$10,296$43,231$44,227$43,087
Other Equity$212,288$154,639$119,030$112,576
Total Equity-$38,703$3,709$2,066$37,765
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$92,723$64,827$66,769$73,580
Net Debt$42,531$18,273$21,344-$9,986